Literature DB >> 29769372

IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease.

Hugo Morales-Briceño1, Belinda Cruse1, Alessandro F Fois1, Ming-Wei Lin1, Jocelyn Jiang1, Dev Banerjee1, Ron Grunstein1, Winny Varikatt1, Michael Rodriguez1, Claire Shepherd1, Victor S C Fung2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29769372     DOI: 10.1212/WNL.0000000000005679

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

Review 1.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

Review 2.  Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review.

Authors:  Pearlynne L H Chong; Dea Garic; Mark D Shen; Iben Lundgaard; Amy J Schwichtenberg
Journal:  Sleep Med Rev       Date:  2021-11-18       Impact factor: 11.609

3.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

4.  Persistence of Facio-Skeletal Myorhythmia During Sleep in anti-IgLON5 Disease.

Authors:  Gian Maria Asioli; Giovanna Calandra-Buonaura; Vincenzo Mastrangelo; Giulia Pierangeli; Carles Gaig; Joan Santamaria; Pietro Cortelli; Federica Provini
Journal:  Mov Disord Clin Pract       Date:  2021-02-25

5.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

6.  Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis.

Authors:  Tetyana Blinder; Jan Lewerenz
Journal:  Front Neurol       Date:  2019-07-25       Impact factor: 4.003

7.  Ocular Motor Abnormalities in Anti-IgLON5 Disease.

Authors:  Stefan Macher; Ivan Milenkovic; Tobias Zrzavy; Romana Höftberger; Stefan Seidel; Evelyn Berger-Sieczkowski; Thomas Berger; Paulus S Rommer; Gerald Wiest
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

Review 8.  Anti-IgLON5 Disease - The Current State of Knowledge and Further Perspectives.

Authors:  Natalia Madetko; Weronika Marzec; Agata Kowalska; Dominika Przewodowska; Piotr Alster; Dariusz Koziorowski
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

Review 9.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

10.  Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.

Authors:  Maria Elena Erro; Lidia Sabater; Laura Martínez; María Herrera; Aiora Ostolaza; Iñaki García de Gurtubay; Teresa Tuñón; Francesc Graus; Ellen Gelpi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.